<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the relationship between use of <z:hpo ids='HP_0002099'>asthma</z:hpo> medication and nitrates and risk of <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e>, <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: Data were collected on use of <z:hpo ids='HP_0002099'>asthma</z:hpo> medication and nitrates at least 1 year before interview from patients with <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e>, <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Associations between use of <z:hpo ids='HP_0002099'>asthma</z:hpo> medications and nitrates and the risk of <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e>, <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> were estimated using multiple logistic regression </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Nine hundred and forty-one subjects were recruited: 230 reflux <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e>, 224 Barrett's oesophagus, 227 oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> patients and 260 population controls </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> patients were more likely than controls to have had a diagnosis of <z:hpo ids='HP_0002099'>asthma</z:hpo> (odds ratio 2.15, 95% confidence interval 1.15-4.03) and to have used <z:hpo ids='HP_0002099'>asthma</z:hpo> medications (odds ratio 2.13, 95% confidence interval 1.09-4.16) </plain></SENT>
<SENT sid="5" pm="."><plain>No significant associations were observed between use of <z:hpo ids='HP_0002099'>asthma</z:hpo> medication or nitrates and <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e> or oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">Gastro-oesophageal reflux</z:e> symptoms appear to confound the association between <z:hpo ids='HP_0002099'>asthma</z:hpo> medication use and <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>However, it is possible that <z:hpo ids='HP_0002099'>asthma</z:hpo> medications may increase the risk of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> by other mechanisms </plain></SENT>
</text></document>